Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://apellis.com/sitemap_index.xml # --------------------------- # END YOAST |
Title | Official Home Page of the Apellis Pharmaceuticals Corporate Site | Apellis |
Description | Courageous Science + Apellis is a global biopharmaceutical company that develops life-changing therapies. By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive activation of the complement cascade, including those within hematology, |
Keywords | N/A |
WebSite | apellis.com |
Host IP | 173.237.160.161 |
Location | United States |
Site | Rank |
US$70,872,916
Last updated: 2023-04-29 01:41:54
apellis.com has Semrush global rank of 149,342. apellis.com has an estimated worth of US$ 70,872,916, based on its estimated Ads revenue. apellis.com receives approximately 8,177,645 unique visitors each day. Its web server is located in United States, with IP address 173.237.160.161. According to SiteAdvisor, apellis.com is safe to visit. |
Purchase/Sale Value | US$70,872,916 |
Daily Ads Revenue | US$65,422 |
Monthly Ads Revenue | US$1,962,635 |
Yearly Ads Revenue | US$23,551,616 |
Daily Unique Visitors | 545,177 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
apellis.com. | A | 600 | IP: 173.237.160.161 |
apellis.com. | NS | 3600 | NS Record: ns05.domaincontrol.com. |
apellis.com. | NS | 3600 | NS Record: ns06.domaincontrol.com. |
apellis.com. | MX | 600 | MX Record: 0 apellis-com.mail.protection.outlook.com. |
apellis.com. | TXT | 600 | TXT Record: logmein-verification-code=0bede69f-fc72-4bad-8814-003ae7ba4473 |
apellis.com. | TXT | 600 | TXT Record: v=spf1 include:spf.protection.outlook.com include:mailsenders.netsuite.com include:_spf.salesforce.com include:_spf.psm.knowbe4.com -all |
apellis.com. | TXT | 600 | TXT Record: docusign=512ff9a4-6610-4487-b7a8-406d670c5b69 |
apellis.com. | TXT | 600 | TXT Record: docusign=6f257d3e-07b5-4b4a-af86-0de2827ed006 |
apellis.com. | TXT | 600 | TXT Record: google-site-verification=FlAMR79eRMolnlRS_vso6Bnd5uMBqrQdHOApU_zqRQs |
apellis.com. | TXT | 600 | TXT Record: ZOOM_verify_LcHhUskwRD2mn-w23OvusA |
apellis.com. | TXT | 600 | TXT Record: apple-domain-verification=z0bl5YxpN2iCxa6I |
apellis.com. | TXT | 600 | TXT Record: MS=ms51991334 |
Now Approved in the US » © 2023 Apellis Pharmaceuticals, Inc. All rights reserved. 2/23. US-PEGGA-2200105. v1.0. Healthcare Providers For Patients About Us Who We Are Our Team Board of Directors Corporate Giving Our Science Science of C3 Our Pipeline Clinical Trials Focus Areas Ophthalmology Rare Disease Research Our Products Careers Our Culture Benefits Open Positions Investors & Media Overview Stock Information News Releases Perspectives Events & Presentations Corporate Governance Financials & Filings Investor FAQs Investor Resources Home About Us Who We Are Our Team Board of Directors Corporate Giving Our Science Science of C3 Our Pipeline Clinical Trials Focus Areas Ophthalmology Rare Disease Research Our Products Careers Our Culture Benefits Open Positions Investors & Media Overview Stock Information News Releases Perspectives Events & Presentations Corporate Governance Financials & Filings Investor FAQs Investor Resources Healthcare Providers For Patients Courageous Science + |
HTTP/1.1 303 See Other Content-Length: 143 Content-Type: text/html; charset=UTF-8 Location: https://apellis.com/ Server: Microsoft-IIS/10.0 X-Powered-By: ASP.NET Date: Thu, 21 Oct 2021 23:21:47 GMT HTTP/2 200 content-length: 0 content-type: text/html; charset=UTF-8 last-modified: Thu, 21 Oct 2021 18:07:50 GMT server: Microsoft-IIS/10.0 x-powered-by: PHP/7.4.1 x-powered-by: ASP.NET date: Thu, 21 Oct 2021 23:21:47 GMT |
Domain Name: APELLIS.COM Registry Domain ID: 1416945203_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2017-12-14T18:56:34Z Creation Date: 2008-03-07T19:13:36Z Registry Expiry Date: 2027-03-07T19:13:36Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS05.DOMAINCONTROL.COM Name Server: NS06.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T18:10:48Z <<< |